If HDL-bound Lp-PLA2 does play roles in cardiovascular diseases, resistance of HDL-bound Lp-PLA2 to darapladib may also contribute to the failure of the clinical studies. This evidence concerns the gene PLA2G7 and cardiovascular disorder.